Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 09/30/2019

Month EndAs of 09/30/2019 1 Yr 3 Yr 5 Yr 10 Yr Since Inception Inception 09/15/1997
Fund without Sales Charge (%) (NAV) -17.49 0.01 0.70 13.02 10.06
Fund with Sales Charge (%) (POP) -22.02 -1.85 -0.44 12.38 9.78
NASDAQ Biotechnology Index (%) -18.45 1.10 1.81 14.19 10.87
S&P 500 Index (%) 4.25 13.40 10.84 13.24 7.48
Quarter EndAs of 09/30/2019 1 Yr 3 Yr 5 Yr 10 Yr Since Inception Inception 09/15/1997
Fund without Sales Charge (%) (NAV) -17.49 0.01 0.70 13.02 10.06
Fund with Sales Charge (%) (POP) -22.02 -1.85 -0.44 12.38 9.78
NASDAQ Biotechnology Index (%) -18.45 1.10 1.81 14.19 10.87
S&P 500 Index (%) 4.25 13.40 10.84 13.24 7.48

After-Tax Average Annual Total Returns [further-information] As of 09/30/2019

Month EndAs of 09/30/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -18.41 -0.97 -0.64 11.81
Fund without Sales Charge (%) (NAV) After Shares Sold -10.13 -0.17 0.29 10.64
Fund with Sales Charge (%) (POP) Before Shares Sold -22.90 -2.81 -1.75 11.18
Fund with Sales Charge (%) (POP) After Shares Sold -12.83 -1.57 -0.57 10.07
Quarter EndAs of 09/30/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -18.41 -0.97 -0.64 11.81
Fund without Sales Charge (%) (NAV) After Shares Sold -10.13 -0.17 0.29 10.64
Fund with Sales Charge (%) (POP) Before Shares Sold -22.90 -2.81 -1.75 11.18
Fund with Sales Charge (%) (POP) After Shares Sold -12.83 -1.57 -0.57 10.07

Calendar Year Returns

2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Fund without Sales Charge (%) (NAV) -15.72 18.80 -17.16 5.50 33.91 68.64 29.35 8.35 17.28 11.83
Fund with Sales Charge (%) (POP) -20.35 11.97 -21.92 -0.57 26.22 58.95 21.90 2.12 10.54 5.41
NASDAQ Biotechnology Index (%) -9.32 21.06 -21.68 11.42 34.32 65.97 32.29 12.08 15.25 15.84
S&P 500 Index (%) -4.38 21.83 11.96 1.38 13.69 32.39 16.00 2.11 15.06 26.46

Cumulative Total Returns [further-information] As of 09/30/2019

Month EndAs of 09/30/2019 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -14.27 6.21 -17.49 0.04 3.54 239.92 726.94
Fund with Sales Charge (%) (POP) -18.98 0.37 -22.02 -5.46 -2.16 221.19 681.31
NASDAQ Biotechnology Index (%) -8.76 2.76 -18.45 3.32 9.39 276.85 872.33
S&P 500 Index (%) 1.70 20.55 4.25 45.80 67.27 246.74 390.39
Quarter EndAs of 09/30/2019 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -14.27 6.21 -17.49 0.04 3.54 239.92 726.94
Fund with Sales Charge (%) (POP) -18.98 0.37 -22.02 -5.46 -2.16 221.19 681.31
NASDAQ Biotechnology Index (%) -8.76 2.76 -18.45 3.32 9.39 276.85 872.33
S&P 500 Index (%) 1.70 20.55 4.25 45.80 67.27 246.74 390.39

MODERN PORTFOLIO THEORY (MPT) STATISTICSAs of 09/30/2019 (updated monthly)

3 YR 5 YR 10 YR
Standard Deviation (Fund) 22.47 24.19 22.62
Standard Deviation (NASDAQ Biotechnology Index) 20.85 22.75 21.12
Beta 1.04 1.04 1.03
Sharpe Ratio -0.07 -0.01 0.55
Information Ratio -0.20 -0.20 -0.20
Tracking Error 5.65 5.49 5.90

ADDITIONAL RISK STATISTICSAs of 09/30/2019 (updated monthly)

3 YR 5 YR 10 YR
Beta Bull 1.07 0.97 1.05
Beta Bear 0.91 1.01 1.01
Bull Bear Capture Ratio 1.01 1.00 0.97
% of Positive Months 50.00 56.67 60.83
Gains/Losses 1.08 1.12 1.62
Maximum Drawdown
23.56 37.64 37.64

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 1.04%
Net Expense Ratio [further-information] 1.02%
Max Initial Sales Charge 5.50%
CDSC 1.00%

Volatility Measures [further-information] As of 09/30/2019 Updated Monthly, based on a 3-year period

Beta 1.04
Sharpe Ratio -0.07
Standard Deviation 22.47

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index